{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:03:00Z","timestamp":1753887780017,"version":"3.41.2"},"reference-count":44,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mem. Inst. Oswaldo Cruz"],"DOI":"10.1590\/0074-02760220039","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T12:06:57Z","timestamp":1668168417000},"source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of the influence of genetic variants in Cereblon gene on the response to the treatment of erythema nodosum leprosum with thalidomide"],"prefix":"10.1590","volume":"117","author":[{"given":"Perp\u00e9tua do Socorro Silva","family":"Costa","sequence":"first","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brazil; Instituto Nacional de Gen\u00e9tica M\u00e9dica Populacional,  Brasil; Universidade Federal do Maranh\u00e3o,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miri\u00e3n Ferr\u00e3o","family":"Maciel-Fiuza","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brazil; Instituto Nacional de Gen\u00e9tica M\u00e9dica Populacional,  Brasil; Hospital de Cl\u00ednicas de Porto Alegre,  Brasil; Universidade Federal do Rio Grande do Sul,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thayne Woycinck","family":"Kowalski","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brazil; Instituto Nacional de Gen\u00e9tica M\u00e9dica Populacional,  Brasil; Hospital de Cl\u00ednicas de Porto Alegre,  Brasil; Universidade Federal do Rio Grande do Sul,  Brazil; Hospital de Cl\u00ednicas de Porto Alegre,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas Rosa","family":"Fraga","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas de Porto Alegre,  Brasil; Universidade Federal do Rio Grande do Sul,  Brazil; Hospital de Cl\u00ednicas de Porto Alegre,  Brasil; Universidade Federal do Rio Grande do Sul,  Brazil; Universidade Federal do Rio Grande do Sul,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maril\u00e9a Furtado","family":"Feira","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brazil; Instituto Nacional de Gen\u00e9tica M\u00e9dica Populacional,  Brasil; Hospital de Cl\u00ednicas de Porto Alegre,  Brasil; Universidade Federal do Rio Grande do Sul,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds Marcelo Aranha","family":"Camargo","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil; Centro de Pesquisa em Medicina Tropical,  Brasil; Instituto Nacional de Ci\u00eancia e Tecnologia de Epidemiologia da Amaz\u00f4nia Ocidental,  Brasil; Centro Universit\u00e1rio S\u00e3o Lucas,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele Iop de Oliveira","family":"Caldoncelli","sequence":"additional","affiliation":[{"name":"Centro de Refer\u00eancia Nacional em Dermatologia Sanit\u00e1ria Dona Lib\u00e2nia,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Irismar da Silva","family":"Silveira","sequence":"additional","affiliation":[{"name":"Centro de Refer\u00eancia Nacional em Dermatologia Sanit\u00e1ria Dona Lib\u00e2nia,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lav\u00ednia","family":"Schuler-Faccini","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brazil; Instituto Nacional de Gen\u00e9tica M\u00e9dica Populacional,  Brasil; Hospital de Cl\u00ednicas de Porto Alegre,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6339-4869","authenticated-orcid":false,"given":"Fernanda Sales Luiz","family":"Vianna","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brazil; Instituto Nacional de Gen\u00e9tica M\u00e9dica Populacional,  Brasil; Hospital de Cl\u00ednicas de Porto Alegre,  Brasil; Universidade Federal do Rio Grande do Sul,  Brazil; Hospital de Cl\u00ednicas de Porto Alegre,  Brasil; Universidade Federal do Rio Grande do Sul,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2022]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003431","article-title":"Household costs of leprosy reactions (ENL) in rural India","volume":"9","author":"Chandler DJ","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"868","DOI":"10.4269\/ajtmh.2006.74.868","article-title":"Clinical course of erythema nodosum leprosum an 11-year cohort study in Hyderabad, India","volume":"74","author":"Pocaterra L","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.actatropica.2018.02.026","article-title":"Erythema nodosum leprosum update and challenges on the treatment of a neglected condition","volume":"183","year":"2018","journal-title":"Acta Tropica"},{"issue":"7-8","key":"ref4","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.biocel.2007.01.022","article-title":"The thalidomide saga","volume":"39","author":"Melchert M","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/cpt196563303","article-title":"Thalidomide in the treatment of lepra reactions","volume":"6","author":"Sheskin J","year":"1965","journal-title":"Clin Pharmacol Ther"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.2174\/0929867324666170601074646","article-title":"A Mini-review on thalidomide chemistry, mechanisms of action, therapeutic potential and anti-angiogenic properties in multiple myeloma","volume":"24","author":"Mercurio A","year":"2017","journal-title":"Curr Med Chem"},{"issue":"7216","key":"ref7","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(61)90927-8","article-title":"Thalidomide and congenital abnormalities","volume":"278","author":"Mcbride WG","year":"1961","journal-title":"The Lancet"},{"issue":"7219","key":"ref8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0140-6736(62)92665-X","article-title":"Thalidomide and congenital abnormalities","volume":"279","author":"Lenz W","year":"1962","journal-title":"The Lancet"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12185-016-2073-4","article-title":"Cereblon and its downstream substrates as molecular targets of immunomodulatory drugs","volume":"104","author":"Ito T","year":"2016","journal-title":"Int J Hematol"},{"issue":"21","key":"ref10","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199911183412102","article-title":"Antitumor activity of thalidomide in refractory multiple myeloma","volume":"341","author":"Singhal S","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1084\/jem.177.6.1675","article-title":"Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation","volume":"177","author":"Moreira AL","year":"1993","journal-title":"J Exp Med"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2174\/1566524017666170331162315","article-title":"The molecular mechanisms of thalidomide teratogenicity and implications for modern medicine","volume":"17","author":"Knobloch J","year":"2017","journal-title":"Curr Mol Med"},{"issue":"5971","key":"ref13","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1177319","article-title":"Identification of a primary target of thalidomide teratogenicity","volume":"327","author":"Ito T","year":"2010","journal-title":"Science"},{"issue":"26","key":"ref14","doi-asserted-by":"crossref","first-page":"10141","DOI":"10.1074\/jbc.RA118.002246","article-title":"Cereblon suppresses the lipopolysaccharide-induced inflammatory response by promoting the ubiquitination and degradation of c-Jun","volume":"293","author":"Yang J","year":"2018","journal-title":"J Biol Chem"},{"issue":"18","key":"ref15","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood-2011-05-356063","article-title":"Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide","volume":"118","author":"Zhu YX","year":"2011","journal-title":"Blood"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1038\/leu.2012.119","article-title":"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide","volume":"26","author":"Lopez-Girona A","year":"2012","journal-title":"Leukemia"},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00277-014-2063-7","article-title":"Expression of cereblon protein assessed by immunohistochemical staining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma","volume":"93","author":"Huang SY","year":"2014","journal-title":"Ann Hematol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"110114","DOI":"10.1016\/j.biopha.2020.110114","article-title":"Recent advances in the molecular mechanism of thalidomide teratogenicity","volume":"127","author":"Gao S","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"ref19","first-page":"1","article-title":"Cereblon gene variants and clinical outcome in multiple myeloma patients treated with lenalidomide","volume":"9","author":"Huang PA","year":"2019","journal-title":"Sci Rep"},{"issue":"35","key":"ref20","doi-asserted-by":"crossref","first-page":"24054","DOI":"10.18632\/oncotarget.25307","article-title":"Polymorphisms in the promoter region of the CRBN gene as a predictive factor for the first-line CTD therapy in multiple myeloma patients","volume":"9","author":"Szudy-Szczyrek A","year":"2018","journal-title":"Oncotarget"},{"issue":"Suppl 1","key":"ref21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00005-016-0442-6","article-title":"Cereblon and IRF4 variants affect risk and response to treatment in multiple myeloma","volume":"64","author":"Butrym A","year":"2016","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/bjh.15972","article-title":"Polymorphisms in the promotor region of the CRBN gene as a predictive factor for peripheral neuropathy in the course of thalidomide-based chemotherapy in multiple myeloma patients","volume":"186","author":"Mlak R","year":"2019","journal-title":"Br J Haematol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.reprotox.2016.10.003","article-title":"Genomic and in silico analyses of CRBN gene and thalidomide embryopathy in humans","volume":"66","author":"Vianna FSL","year":"2016","journal-title":"Reprod Toxicol"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang KY","year":"1986","journal-title":"Biometrika"},{"issue":"17","key":"ref25","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.2217\/pgs-2016-0131","article-title":"The effect of SNPs in CYP450 in chloroquine\/primaquine Plasmodium vivax malaria treatment","volume":"17","author":"Sortica VA","year":"2016","journal-title":"Pharmacogenomics"},{"issue":"3","key":"ref26","first-page":"799","article-title":"An E-M algorithm and testing strategy for multiple-locus haplotypes","volume":"56","author":"Long JC","year":"1995","journal-title":"Am J Hum Genet"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/379378","article-title":"A comparison of Bayesian methods for haplotype reconstruction from population genotype data","volume":"73","author":"Stephens M","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/319501","article-title":"A new statistical method for haplotype reconstruction from population data","volume":"68","author":"Stephens M","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/bjh.12708","article-title":"Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN","volume":"164","author":"Gandhi AK","year":"2014","journal-title":"Br J Haematol"},{"issue":"9","key":"ref30","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00018-010-0619-9","article-title":"Teratogenic effects of thalidomide Molecular mechanisms","volume":"68","author":"Ito T","year":"2011","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.leukres.2013.08.015","article-title":"The clinical significance of cereblon expression in multiple myeloma","volume":"38","author":"Schuster SR","year":"2014","journal-title":"Leuk Res"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/10428194.2018.1466290","article-title":"Expression of CRBN, IKZF1, and IKZF3 does not predict lenalidomide sensitivity and mutations in the cereblon pathway are infrequent in multiple myeloma","volume":"60","author":"Dimopoulos K","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"ref33","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nsmb.2874","article-title":"Structure of the human cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs","volume":"21","author":"Chamberlain PP","year":"2014","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"ref34","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/bjh.12338","article-title":"High expression of cereblon (CRBN) is associated with improved clinical response in patients with multiple myeloma treated with lenalidomide and dexamethasone","volume":"161","author":"Heintel D","year":"2013","journal-title":"Br J Haematol"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3109\/10428194.2012.728597","article-title":"Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma","volume":"54","author":"Zhu YX","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.leukres.2015.10.007","article-title":"Polymorphisms within beta-catenin encoding gene affect multiple myeloma development and treatment","volume":"39","author":"Butrym A","year":"2015","journal-title":"Leuk Res"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/10428194.2019.1689391","article-title":"Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed\/refractory multiple myeloma patients treated with lenalidomide a pharmacogenetic study from the IMMEnSE consortium","volume":"61","author":"Iskierka-Jazdzewska E","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.47276\/lr.78.3.197","article-title":"The role of thalidomide in the management of erythema nodosum leprosum","volume":"78","author":"Walker SL","year":"2007","journal-title":"Lepr Rev"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1440-0960.2002.00608.x","article-title":"Thalidomide in dermatology","volume":"43","author":"Wines NY","year":"2002","journal-title":"Aust J Dermatol"},{"key":"ref40","article-title":"Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide","author":"Feuth M","year":"2008","journal-title":"Lepr Rev"},{"issue":"9","key":"ref41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004065","article-title":"ENLIST 1 an international multi-centre cross-sectional study of the clinical features of erythema nodosum leprosum","volume":"9","author":"Walker SL","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"ref42","first-page":"384","article-title":"Erythema nodosum leprosum case series report clinical profile, immunological basis and treatment implemented in health services","volume":"37","author":"Guerra JG","year":"2004","journal-title":"Rev Soc Bras Med Trop"},{"issue":"10","key":"ref43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002440","article-title":"A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction","volume":"7","author":"Voorend CG","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.4049\/jimmunol.1600042","article-title":"DNA Sensing via TLR-9 constitutes a major innate immunity pathway activated during erythema nodosum leprosum","volume":"197","author":"Dias AA","year":"2016","journal-title":"J Immunol"}],"container-title":["Mem\u00f3rias do Instituto Oswaldo Cruz"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0074-02762022000101131&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T12:07:21Z","timestamp":1668168441000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0074-02762022000101131&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":44,"alternative-id":["S0074-02762022000101131"],"URL":"https:\/\/doi.org\/10.1590\/0074-02760220039","relation":{},"ISSN":["1678-8060","0074-0276"],"issn-type":[{"type":"electronic","value":"1678-8060"},{"type":"print","value":"0074-0276"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"e220039"}}